01.06.2023
PRICE INQUIRY no. NETLA/5/2023/API - being conducted as a market assessment study
In connection with the implementation of the project titled “Design and development of an innovative solution – a complex, two-component medicinal product in the…
26.05.2023
PRICE INQUIRY no. NETLA/4/2023/API - being conducted as a market assessment study
In connection with the implementation of the project titled “Design and development of an innovative solution – a complex, two-component medicinal product in the…
24.05.2023
PRICE INQUIRY no. SEMA/5/2023/API - being conducted as a market assessment study
In connection with the implementation of the project titled “Design and development of an innovative solution - a generic drug belonging to the class…
28.04.2023
PRICE INQUIRY no. NUSI/31/PR13783/2023 - being conducted as a market assessment study
In connection with the implementation of the project titled “Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and…
28.04.2023
PRICE INQUIRY no. NUSI/30/PR13159/2023 - being conducted as a market assessment study
In connection with the implementation of the project titled “Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and…
18.04.2023
PRICE INQUIRY no. NETLA/3/68779/2023 - being conducted as a market assessment study
In connection with the implementation of the project titled “Development(Description) and development of an innovative solution - a complex, two-component medicinal product in the…
Polpharma Group
We are the largest Polish manufacturer of pharmaceuticals and a leader of the…
read more